Marco Velasco-Velázquez

Cited by

	All	Since 2019
Citations	3433	2009
h-index	28	23
i10-index	48	41

420

210

105

315

200320042005200620072008200920102011201220132014201520162017201820192020202120222023202413 20 18 15 29 30 39 31 38 59 108 123 150 213 242 263 342 366 408 390 370 132

Public access

View all

22 articles

0 articles

available

not available

Based on funding mandates

Co-authors

Pavon LeninInstituto Nacional de Psiquiatria Ramon de la Fuente MuñizVerified email at imp.edu.mx
Marisol De La Fuente GranadaInstituto de Investigaciones Biomedicas, UNAMVerified email at iibiomedicas.unam.mx
Angel J. Ruiz MorenoPostdoctoral Researcher at University Medical Center GroningenVerified email at comunidad.unam.mx
Michael P. Lisanti, MD-PhD, FRSA, FR...Professor and Chair of Translational Medicine, University of Salford (Greater Manchester)Verified email at salford.ac.uk
Luis Vallejo-CastilloInvestigador, UDIBI-IPNVerified email at ipn.mx
Timothy G PestellResearch Assistant, Thomas Jefferson UniversityVerified email at jefferson.edu
Gilberto Perez SánchezInvestigador en Ciencias Médicas, Instituto Nacional de Psiquiatría Ramón de la Fuente MuñízVerified email at imp.edu.mx
Matthew GrovesUniversity of GroningenVerified email at rug.nl
Emanuele LoroUniversity of Pennsylvania - Department of PhysiologyVerified email at mail.med.upenn.edu
L Enrique Becerril-VillanuevaInstituto Nacional de PsiquiatriaVerified email at imp.edu.mx
Silvia Anahi Valdés-RivesDoctora en Ciencias, Universidad Nacional Autónoma de MéxicoVerified email at fccc.edu
Ivan VelascoInstituto de Fisiologia Celular-Neurociencias, Universidad Nacional Autonoma de MexicoVerified email at ifc.unam.mx
Jorge Melendez-ZajglaINMEGENVerified email at inmegen.gob.mx
Vilma Maldonado lagunasInmegenVerified email at inmegen.gob.mx
Karla Vazquez-SantillanINMEGENVerified email at inmegen.gob.mx
jose enrique herbert puchetaEscuela Nacional de Ciencias Biológicas Instituto Politécnico NacionalVerified email at ipn.mx
Chenguang WangLIPOGEN LLC.Verified email at lipogenes.com
Gabriele Di SantePostdoctoral Fellow, Thomas Jefferson UniversityVerified email at jefferson.edu
George C PrendergastProfessor, President & CEO, Lankenau Institute for Medical ResearchVerified email at limr.org
Miguel Angel Becerril-GarciaProfessor of Microbiology, UANL, MéxicoVerified email at uanl.edu.mx

Marco Velasco-Velázquez

Profesor

Verified email at unam.mx - Homepage

Pharmacology Cancer Biology Experimental Therapeutics


Title Sort by citations Sort by year Sort by title	Cited by Cited by	Year
CCR5 antagonist blocks metastasis of basal breast cancer cells M Velasco-Velázquez, X Jiao, M De La Fuente, TG Pestell, A Ertel, ... Cancer research 72 (15), 3839-3850, 2012	325	2012
Immunomodulatory effects mediated by serotonin R Arreola, E Becerril-Villanueva, C Cruz-Fuentes, MA Velasco-Velázquez, ... Journal of immunology research 2015, 2015	222	2015
Breast cancer stem cells MA Velasco-Velázquez, N Homsi, M De La Fuente, RG Pestell The international journal of biochemistry & cell biology 44 (4), 573-577, 2012	222	2012
The role of breast cancer stem cells in metastasis and therapeutic implications MA Velasco-Velázquez, VM Popov, MP Lisanti, RG Pestell The American journal of pathology 179 (1), 2-11, 2011	205	2011
Overview of cyclins D1 function in cancer and the CDK inhibitor landscape: past and present MC Casimiro, M Velasco-Velázquez, C Aguirre-Alvarado, RG Pestell Expert opinion on investigational drugs 23 (3), 295-304, 2014	195	2014
IL-8 and IL-6 primarily mediate the inflammatory response in fibromyalgia patients D Mendieta, DL De la Cruz-Aguilera, MI Barrera-Villalpando, ... Journal of neuroimmunology 290, 22-25, 2016	164	2016
Macrophage—Mycobacterium tuberculosis interactions: role of complement receptor 3 MA Velasco-Velázquez, D Barrera, A González-Arenas, C Rosales, ... Microbial pathogenesis 35 (3), 125-131, 2003	155	2003
CCR5 governs DNA damage repair and breast cancer stem cell expansion X Jiao, MA Velasco-Velazquez, M Wang, Z Li, H Rui, AR Peck, JE Korkola, ... Cancer research 78 (7), 1657-1671, 2018	123	2018
The potential to target CCL5/CCR5 in breast cancer M Velasco-Velázquez, W Xolalpa, RG Pestell Expert opinion on therapeutic targets 18 (11), 1265-1275, 2014	120	2014
4-Hydroxycoumarin disorganizes the actin cytoskeleton in B16–F10 melanoma cells but not in B82 fibroblasts, decreasing their adhesion to extracellular matrix proteins and motility MA Velasco-Velázquez, J Agramonte-Hevia, D Barrera, ... Cancer letters 198 (2), 179-186, 2003	105	2003
Apoptotic signaling pathways in glioblastoma and therapeutic implications SA Valdés-Rives, D Casique-Aguirre, L Germán-Castelán, ... BioMed research international 2017, 2017	103	2017
The CCL5/CCR5 axis promotes metastasis in basal breast cancer M Velasco-Velázquez, RG Pestell Oncoimmunology 2 (4), e23660, 2013	93	2013
Examining the role of cyclin D1 in breast cancer MA Velasco-Velázquez, Z Li, M Casimiro, E Loro, N Homsi, RG Pestell Future Oncology 7 (6), 753-765, 2011	93	2011
Decrease of cyclin D1 in the human lung adenocarcinoma cell line A-427 by 7-hydroxycoumarin FA Jiménez-Orozco, JS Lopez-González, A Nieto-Rodriguez, ... Lung Cancer 34 (2), 185-194, 2001	91	2001
Gram-negative bacteria and phagocytic cell interaction mediated by complement receptor 3 J Agramonte-Hevia, A González-Arenas, D Barrera, ... FEMS Immunology & Medical Microbiology 34 (4), 255-266, 2002	87	2002
CCR5 receptor antagonists block metastasis to bone of v-Src oncogene–transformed metastatic prostate cancer cell lines D Sicoli, X Jiao, X Ju, M Velasco-Velazquez, A Ertel, S Addya, Z Li, ... Cancer research 74 (23), 7103-7114, 2014	80	2014
NF-kappaΒ-inducing kinase regulates stem cell phenotype in breast cancer K Vazquez-Santillan, J Melendez-Zajgla, LE Jimenez-Hernandez, ... Scientific reports 6 (1), 37340, 2016	76	2016
Mesenchymal stromal cells derived from cervical cancer produce high amounts of adenosine to suppress cytotoxic T lymphocyte functions M de Lourdes Mora-García, R García-Rocha, O Morales-Ramírez, ... Journal of Translational Medicine 14, 1-14, 2016	66	2016
Repurposing the HCV NS3–4A protease drug boceprevir as COVID-19 therapeutics R Oerlemans, AJ Ruiz-Moreno, Y Cong, ND Kumar, ... RSC medicinal chemistry 12 (3), 370-379, 2021	63	2021
Cyclin D1 restrains oncogene-induced autophagy by regulating the AMPK–LKB1 signaling axis MC Casimiro, G Di Sante, A Di Rocco, E Loro, C Pupo, TG Pestell, ... Cancer research 77 (13), 3391-3405, 2017	56	2017

The system can't perform the operation now. Try again later.

Articles 1–20

Citations per year

Duplicate citations

Merged citations

Add co-authorsCo-authors

Follow

Cited by

Co-authors